Made for Childhood.
Made for Control.
With the insulin pump that predicts and helps prevent highs and lows.
What People Are Saying
Hear from parents how Tandem automated delivery systems have made life better for the whole family.
Going from shots to the Tandem Mobi has been life-changing. The accuracy and control we have now has been great.
Ginny
Mother to Ben, diagnosed 2024
Shannon
Mother to Raelynn, diagnosed 2022
Markquetto
Mother to Syncere, diagnosed 2023
Maria
Mother to Jarim, diagnosed 2020
Individual symptoms, situations, circumstances, and results may vary.
Made for Childhood
Get started today and learn how a Tandem pump benefits the whole family.
* With optimized correction factor based on “rule of less than 1600.”
References
1. Breton MD, Kovatchev BP. Diabetes Technol Ther. 2021;23(9):601-608.
2. Mueller L, et al. Diabetes. 2020;69(Supplement_1):95-LB.
3. Messer LH, Breton M. Diabetes Technol Ther. 2023;25(12):877-882.
Note: Studies 1 and 2 were conducted using a t:slim X2 insulin pump with Control-IQ technology and a Dexcom G6 CGM sensor.
Important Safety Information
RX ONLY.
Indications for Use
Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater.
Warning: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely.
Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.